Skip to main content

Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · IEX Real-Time Price · USD
13.55 -0.38 (-2.73%)
Oct 15, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
1.350.93
Research & Development
88.58
Operating Expenses
9.359.5
Operating Income
-9.35-9.5
Other Expense / Income
-2.02-1.6
Pretax Income
-7.33-7.91
Net Income
-7.33-7.91
Preferred Dividends
0-0.22
Net Income Common
-7.33-7.69
Shares Outstanding (Basic)
00
Shares Outstanding (Diluted)
00
Shares Change
-2.71%-
EPS (Basic)
-17.48-17.84
EPS (Diluted)
-17.48-17.84
Free Cash Flow Per Share
-17.77-15.83
EBITDA
-7.33-7.91
EBIT
-7.33-7.91